Risk scoring for time to end-stage knee osteoarthritis: data from the Osteoarthritis Initiative
R Dunn1, J Greenhouse1, D James2
1Department of Statistics & Data Science, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.
Osteoarthritis and Cartilage
|May 17, 2020
Summary
Researchers developed a risk score to predict end-stage knee osteoarthritis (OA) progression within four years. This tool aids in identifying patients at high risk for faster disease advancement, improving clinical trial recruitment.
Area of Science:
- Orthopedics
- Rheumatology
- Biostatistics
Background:
- Knee osteoarthritis (OA) is a leading cause of disability.
- Predicting the progression of knee OA to end-stage disease is crucial for timely intervention.
- Current methods for predicting OA progression lack precision.
Purpose of the Study:
- To construct and validate a risk score for predicting progression to end-stage knee OA within four years.
- To identify key baseline predictors of rapid knee OA progression.
- To aid in the selection of participants for clinical trials targeting knee OA.
Main Methods:
- Utilized the Osteoarthritis Initiative (OAI) longitudinal dataset.
- Employed interval-censored survival forests to identify significant predictors.
- Developed an interval-censored Cox model incorporating nine key variables.
- Validated the risk score on an independent test set.
Main Results:
- The risk score demonstrated strong predictive performance with a concordance index of 0.86.
- Achieved an AUC of 0.87 for predicting end-stage knee OA within 24-48 months.
- Risk stratification identified a subset of patients with a high likelihood of progressing to end-stage OA.
Conclusions:
- An interpretable risk score for end-stage knee OA progression has been successfully developed and validated.
- The risk score can significantly enhance the efficiency of clinical trial enrollment by targeting high-risk individuals.
- This tool supports disease-modifying osteoarthritis treatment developers in selecting appropriate candidates.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
326
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
326
01:12Relative Risk
1.6K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.6K